AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE

Rhea-AI Summary

Amgen (NASDAQ: AMGN) will present at the Jefferies Global Healthcare Conference on June 6, 2024, at 9:00 a.m. ET. Key speakers include Peter Griffith, Executive Vice President and CFO, and Ian Thompson, Senior Vice President of U.S. Business Operations. The presentation will be webcast live and accessible to the public, including investors and media, on Amgen's website. The webcast will also be archived for 90 days for replay.

Positive

• Amgen's participation in the Jefferies Global Healthcare Conference could enhance visibility and investor interest.
• Webcast availability allows a broader audience to access the presentation, potentially increasing investor engagement.
• Archival of the webcast for 90 days provides ample opportunity for stakeholders to review the presentation.

Negative

• No concrete new business developments or financial data are disclosed in the press release.
• The presentation's impact on stock performance is uncertain without knowing the specific content.

THOUSAND OAKS, Calif., June 3, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Jefferies Global Healthcare Conference at 9:00 a.m. ET on Thursday, June 6, 2024. Peter Griffith, executive vice president and chief financial officer at Amgen, and Ian Thompson, senior vice president, U.S. Business Operations at Amgen, will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.

In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average^®, and it is also part of the Nasdaq-100 Index^®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.

For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 

CONTACT: Amgen, Thousand Oaks
Elissa Snook, 609-251-1407 (media)
Justin Claeys, 805-313-9775 (investors)  

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-jefferies-global-healthcare-conference-302162239.html

SOURCE Amgen

FAQ

When will Amgen present at the Jefferies Global Healthcare Conference?

Amgen will present on June 6, 2024, at 9:00 a.m. ET.

Who are the key speakers from Amgen at the Jefferies Global Healthcare Conference?

Peter Griffith, Executive Vice President and CFO, and Ian Thompson, Senior Vice President of U.S. Business Operations, will present.

Where can I access the webcast of Amgen's presentation at the Jefferies Global Healthcare Conference?

The webcast will be available on Amgen's website under the Investors section.

How long will the webcast of Amgen's presentation be available for replay?

The webcast will be archived and available for replay for at least 90 days after the event.